Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT06444503
Recruiting Observational

Clinico-biological Collection of Bone, Calcium and Growth Plate Pathologies

NCT06444503 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Toulouse
Phase
Observational
Started
2024-09-16
Last updated
2026-06-05

Condition(s) studied

Bone Disorder

Investigational drug(s) / intervention(s)

Biological samplesBiological

Biological samples: Blood and urine will be taken in larger quantity

Biological: Surgical residues may be preserved in the event of surgery carried out as part of the treatment.

Study summary

The aim of this project is to set up a biological and clinical collection of patients with progressive bone, calcium and growth plate pathologies.

This collection will provide a better understanding of the mechanisms involved in growth plate and bone damage in these diseases and identify factors predictive of progression and new therapeutic targets.

Eligibility

Sex
ALL
Min age
—
Max age
99 Years
Healthy volunteers
No
Inclusion Criteria: * Children (from birth) with growth plate or bone pathology * Patients affiliated to or benefiting from a social security scheme * Patients able to receive information about the study and to understand the information form in order to participate in the study. This implies : * mastery of the French language * Not being subject to a restriction of rights by the judicial authorities * Patients or legal representatives having given their consent to participate in the study (expression of non-opposition). Exclusion Criteria: * Patients under legal protection (guardianship, curatorship or safeguard of justice) * Pregnant or breast-feeding women

Primary outcome measure(s)

  • Building a collection of biological samples and clinical-biological data from patients presenting bone, calcium and growth plate pathologies — Day 0 and through study completion, an average of 5 years
    Blood and urine sampling

Trial sites (1)

FacilityCityRegionStatus
University Toulouse Hospital Toulouse France Recruiting

More University Hospital, Toulouse trials in France

Intragastric Balloon in Obese Patients With Uncontrolled Asthma Recruiting
Study of the Interprofessional Reproducibility of a Clinical Observation Scale for the Development of Very Premature Infants Starting soon
Avacopan Added to Standard-of-care Therapy in ANCA-associated Vasculitis With Severe Kidney Involvement Starting soon
LUng and Cardiac Ultrasound for REspiratory Distress in ElDerly Recruiting
Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06444503 on ClinicalTrials.gov ↗ ← All trials in France